Back
Accenture Plc Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
52
ACN
Accenture Plc
Last Price:
$271.41
Seasonality Move:
0.7%
Buy
65
GPCR
Structure Therapeutics, Inc.
Last Price:
$66.76
Seasonality Move:
-40.78%
Buy
52
Accenture Plc (ACN)
is a Buy
Is Accenture Plc a Buy, Sell or Hold?
-
The current Accenture Plc [ACN] share price is $270.37. The Score for ACN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
ACN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $67.44. The Score for GPCR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACN Stock Price Chart
What is Accenture Plc's stock price today?
-
The Accenture Plc share price today is $270.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACN is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $67.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
ACN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.7 | Buy |
| Relative Strength Index (14 RSI): | 64.58 | Buy |
| Chaikin Money Flow: | -3387719 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (241.52 - 264.48) | Buy |
| Bollinger Bands (100): | (239.27 - 262.15) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.09 | Buy |
| Relative Strength Index (14 RSI): | 78.81 | Buy |
| Chaikin Money Flow: | -1662506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.48 - 52.38) | Buy |
| Bollinger Bands (100): | (16.92 - 37.88) | Buy |
ACN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 268.55 | Buy |
| 20-day SMA: | 255.22 | Buy |
| 50-day SMA: | 249.79 | Buy |
| 200-day SMA: | 278.94 | Sell |
| 8-day EMA: | 266.73 | Buy |
| 20-day EMA: | 259.1 | Buy |
| 50-day EMA: | 253.61 | Buy |
| 200-day EMA: | 276.77 | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.53 | Buy |
| 20-day SMA: | 41.36 | Buy |
| 50-day SMA: | 34.58 | Buy |
| 200-day SMA: | 24.42 | Buy |
| 8-day EMA: | 55.53 | Buy |
| 20-day EMA: | 45.05 | Buy |
| 50-day EMA: | 36.57 | Buy |
| 200-day EMA: | 28.49 | Buy |
Accenture Plc Earnings Growth & ACN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.94 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.14 per share.
Accenture Plc Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||